The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Monday:** U.S. drugmaker Allergan Inc rejected Valeant Pharmaceuticals International Inc's unsolicited takeover offer, saying it substantially undervalued the company.
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN fell by 0.98% or $-1.58/share to $159.72. In the past year, the shares have traded as low as $81.33 and as high as $170.05. On average, 3978680 shares of AGN exchange hands on a given day and today's volume is recorded at 6711944.
Source
